Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, Jee Youn | - |
dc.contributor.author | Lee, Young Seok | - |
dc.contributor.author | Min, Kyung Hoon | - |
dc.contributor.author | Hur, Gyu Young | - |
dc.contributor.author | Lee, Sung Yong | - |
dc.contributor.author | Kang, Kyung Ho | - |
dc.contributor.author | Rhee, Chin Kook | - |
dc.contributor.author | Park, Seoung Ju | - |
dc.contributor.author | Shim, Jae Jeong | - |
dc.date.accessioned | 2021-09-02T21:15:39Z | - |
dc.date.available | 2021-09-02T21:15:39Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 1176-9106 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/80951 | - |
dc.description.abstract | Purpose: Tuberculosis-associated COPD (T-COPD) has clinical characteristics similar to those of smoking-associated COPD (S-COPD), such as dyspnea, sputum production, and acute exacerbation (AE). However, the degree of systemic inflammation and prognosis might be different because of difference in the pathophysiology. The aim of this study was to compare the lung function, systemic inflammatory markers, and their impacts on AE in patients with S-COPD and T-COPD. Patients and methods: We performed a multicenter cross-sectional cohort study. We evaluated clinical characteristics, pulmonary function tests, levels of inflammatory markers, including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and IL-6, and the association of these markers with Au in patients with S-COPD and T-COPD. Results: Patients with T-COPD included more women and had lesser smoking history and higher St George Respiratory Questionnaire score than did patients with S-COPD. Although the FEV1 of both groups was similar, FVC, vital capacity, total lung capacity, and functional residual capacity were lower in patients with T-COPD than in those with S-COPD. CRP, ESR, and IL-6 levels were significantly higher in patients with T-COPD compared to patients with S-COPD. According to a multivariate logistic regression analysis, FEV1 was a significant factor predicting AE in S-COPD, and IL-6 was a significant factor predicting AE in T-COPD. IL-6 level greater than 2.04 pg/mL was a cutoff for predicting exacerbation of T-COPD (sensitivity 84.8%, specificity 59.3%, P<0.001). Conclusion: Patients with T-COPD have higher levels of inflammatory markers, and IL-6 has a predictive value for AE in T-COPD. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | DOVE MEDICAL PRESS LTD | - |
dc.subject | OBSTRUCTIVE PULMONARY-DISEASE | - |
dc.subject | AIR-FLOW OBSTRUCTION | - |
dc.subject | DESTROYED LUNG | - |
dc.subject | BRONCHIECTASIS | - |
dc.subject | OUTCOMES | - |
dc.subject | HOSPITALIZATION | - |
dc.subject | IMPAIRMENT | - |
dc.subject | LIMITATION | - |
dc.subject | IMPACT | - |
dc.subject | RISK | - |
dc.title | Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Oh, Jee Youn | - |
dc.contributor.affiliatedAuthor | Min, Kyung Hoon | - |
dc.contributor.affiliatedAuthor | Hur, Gyu Young | - |
dc.contributor.affiliatedAuthor | Lee, Sung Yong | - |
dc.contributor.affiliatedAuthor | Kang, Kyung Ho | - |
dc.contributor.affiliatedAuthor | Shim, Jae Jeong | - |
dc.identifier.doi | 10.2147/COPD.S177371 | - |
dc.identifier.scopusid | 2-s2.0-85056515421 | - |
dc.identifier.wosid | 000447671600002 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, v.13, pp.3381 - 3387 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | - |
dc.citation.title | INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | - |
dc.citation.volume | 13 | - |
dc.citation.startPage | 3381 | - |
dc.citation.endPage | 3387 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Respiratory System | - |
dc.relation.journalWebOfScienceCategory | Respiratory System | - |
dc.subject.keywordPlus | OBSTRUCTIVE PULMONARY-DISEASE | - |
dc.subject.keywordPlus | AIR-FLOW OBSTRUCTION | - |
dc.subject.keywordPlus | DESTROYED LUNG | - |
dc.subject.keywordPlus | BRONCHIECTASIS | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | HOSPITALIZATION | - |
dc.subject.keywordPlus | IMPAIRMENT | - |
dc.subject.keywordPlus | LIMITATION | - |
dc.subject.keywordPlus | IMPACT | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | COPD | - |
dc.subject.keywordAuthor | tobacco smoke | - |
dc.subject.keywordAuthor | tuberculosis | - |
dc.subject.keywordAuthor | biomarker | - |
dc.subject.keywordAuthor | inflammation | - |
dc.subject.keywordAuthor | exacerbation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.